Workflow
SF GROUP(300817)
icon
Search documents
双飞集团:实际控制人之一顾美娟拟减持0.3665%公司股份
news flash· 2025-07-17 12:23
双飞集团(300817)公告,公司实际控制人之一顾美娟女士计划在公告披露之日起15个交易日后的3个 月内以集中竞价方式减持公司股份80万股,占公司总股本的0.3665%。顾美娟女士目前持有公司738.72 万股,占公司总股本的3.3840%。本次减持计划符合相关法律法规和规范性文件的规定,不会对公司治 理结构、股权结构及未来持续经营产生重大影响,也不会导致公司控制权发生变更。 ...
双飞集团(300817) - 关于公司实际控制人之一减持股份预披露公告
2025-07-17 12:20
证券代码:300817 证券简称:双飞集团 公告编号:2025-033 双飞无油轴承集团股份有限公司 关于公司实际控制人之一减持股份预披露公告 本公司实际控制人之一顾美娟女士保证向本公司提供的信息内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示: 持有双飞无油轴承集团股份有限公司(以下简称"公司"或"本公司")股份7,387,200 股(占本公司总股本比例3.3840%)的实际控制人之一顾美娟女士计划在本公告披露之日起15 个交易日后的3个月内以集中竞价方式减持本公司股份800,000股(占本公司总股本比例 0.3665%)。 一、本次拟减持股东的基本情况 | 序号 | 股东名称 | 持股数量(股) | 占公司总股本比例(%) | | --- | --- | --- | --- | | 1 | 顾美娟 | 7,387,200 | 3.3840 | 5、减持方式:集中竞价; 6、减持数量、占公司总股本的比例: | 序号 | 股东名称 | 减持数量(股) | 占总股本比例(%) | | --- | --- | --- | - ...
研判2025!中国动压油膜滑动轴承行业产业链、市场规模及重点企业分析:产品凭卓越性能领跑高端装备领域,下游行业蓬勃发展驱动市场规模增长[图]
Chan Ye Xin Xi Wang· 2025-06-30 01:28
Industry Overview - The dynamic pressure oil film sliding bearing is widely used in high-end equipment across industries such as power, petrochemical, and metallurgy due to its excellent wear resistance, load capacity, and service life [1][12] - The market demand for dynamic pressure oil film sliding bearings is continuously increasing, driven by the rapid development of downstream industries, particularly in energy, transportation, metallurgy, and chemical sectors [1][12] - The market size of China's dynamic pressure oil film sliding bearing industry is projected to reach approximately 4.428 billion yuan in 2024, representing a year-on-year growth of 7.14% [1][12] Industry Development History - The development of China's dynamic pressure oil film sliding bearing industry has gone through three main stages: the initial stage from the mid-1950s to the late 1970s, the domestic production phase from the 1980s to the 1990s, and the industrialization phase from the early 21st century to the present [4][5] - The industry began with the successful trial production of the first oil film bearing in 1958, marking a significant leap from non-production to production capabilities [4] - The 21st century has seen a surge in demand for dynamic pressure oil film sliding bearings due to rapid advancements in industrial automation and energy generation [5] Industry Chain - The upstream of the dynamic pressure oil film sliding bearing industry includes raw materials and components such as special steel, alloy materials, and lubricants [8] - The midstream involves the production and manufacturing of dynamic pressure oil film sliding bearings [8] - The downstream applications span across energy generation, industrial drives, petrochemical, and shipbuilding industries [8] Current Industry Status - The sliding bearing market in China is expected to reach a production value of 20.61 billion yuan in 2024, with a year-on-year growth of 2.44% [10] - The automotive industry's recovery is injecting strong momentum into the sliding bearing market, with production and sales of automobiles projected to reach 31.282 million and 31.436 million units, respectively, in 2024, reflecting year-on-year growth of 3.7% and 4.5% [10] - The rapid development of wind power, aerospace, and engineering machinery further expands the application scenarios for sliding bearings [10] Key Enterprises - The competitive landscape of China's dynamic pressure oil film sliding bearing industry features leading enterprises like Chongde Technology, which holds 28 core technologies and leads 14 national standards [14] - Chongde Technology has gained recognition from international giants such as Siemens and GE, establishing a leading global market share [6] - Other notable companies include Shinke Co., Ltd. and Changsheng Bearings, which represent the fragmented competition in the mid-to-low-end market [14][17] Industry Development Trends - The industry is undergoing a high-end transformation driven by technological innovation, with companies focusing on breakthroughs in materials, lubrication, and manufacturing processes [19] - Market demand is increasingly concentrated in the fields of new energy and industrial upgrades, particularly in wind power and nuclear power sectors [21] - National policies supporting high-end equipment manufacturing are accelerating the integration of the industry, with a trend towards domestic substitution and increased industry concentration [22]
双飞集团(300817) - 关于控股子公司完成工商变更登记的公告
2025-06-26 03:46
名称:金华市双飞程凯合金材料有限公司 证券代码:300817 证券简称:双飞集团 公告编号:2025-032 双飞无油轴承集团股份有限公司 关于控股子公司完成工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 双飞无油轴承集团股份有限公司(以下简称"公司"或"双飞集团")子公 司金华市双飞程凯合金材料有限公司(以下简称"双飞程凯")因经营管理需要, 对经营范围进行了变更,其他信息不变。具体信息如下: | 变更事项 | 变更前 | 变更后 | | --- | --- | --- | | 经营范围 | 一般项目:有色金属合金制 | 一般项目:有色金属合金制 | | | 造;有色金属合金销售;轴承 | 造;有色金属合金销售;轴承 | | | 制造;轴承销售(除依法须经批 | 制造;轴承销售;再生资源加 | | | 准的项目外,凭营业执照依法 | 工;再生资源销售(除依法须经 | | | 自主开展经营活动)。 | 批准的项目外,凭营业执照依 | | | | 法自主开展经营活动)。 | 近日,双飞程凯已完成工商变更登记手续并收到金华市市场监督管理局核发 ...
京东方A拟收购咸阳彩虹光电科技有限公司30%股权;黑芝麻收到广西证监局警示函|公告精选
Mei Ri Jing Ji Xin Wen· 2025-06-17 13:15
Mergers and Acquisitions - Conch New Materials plans to acquire 80% of Kangning Special Environmental Technology Co., Ltd. and 100% of Zhengzhou Kangning Special Environmental Engineering Technology Co., Ltd. for a total transaction price of approximately 186 million yuan, with final pricing subject to adjustments based on asset valuations at the time of management transfer [1] - BOE Technology Group intends to acquire 30% of Xianyang Rainbow Optoelectronics Technology Co., Ltd. through a public bidding process, with a starting price of 4.849 billion yuan [2] - Wutong Holdings aims to purchase 20% of Suzhou Wutong Intelligent Electronics Co., Ltd. for 84 million yuan to enhance its smart manufacturing business [3] Shareholding Changes - SITW announced that the National Integrated Circuit Industry Investment Fund II has reduced its shareholding from 7.35% to 6.99% after selling 1.45 million shares [4] - Double Fly Group's shareholders plan to collectively reduce their holdings by no more than 210,000 shares, with specific reductions of 90,000 shares and 120,000 shares from two different shareholders [5] - Lixing Co., Ltd. executives plan to reduce their holdings by a total of 218,000 shares, with individual reductions of 88,000 shares, 65,000 shares, and 65,000 shares [6]
双飞集团:顺飞投资和腾飞投资拟分别减持0.4123%和0.5497%公司股份
news flash· 2025-06-17 11:45
Group 1 - The company Shuangfei Group (300817) announced that shareholder Jiaxing Shunfei Equity Investment Management Co., Ltd. plans to reduce its holdings by no more than 900,000 shares, accounting for 0.4123% of the company's total share capital [1] - Another shareholder, Jiaxing Tengfei Equity Investment Management Co., Ltd., plans to reduce its holdings by no more than 1.2 million shares, representing 0.5497% of the company's total share capital [1] - The reason for the reduction is due to the shareholders' own funding needs, and the method of reduction will be through centralized bidding, with the reduction period set for three months starting from 15 trading days after the announcement [1]
双飞集团(300817) - 关于公司股东减持股份预披露公告
2025-06-17 11:42
证券代码: 300817 证券简称:双飞集团 公告编号: 2025-031 2、持有本公司7,949,550股(占本公司总股本比例3.6416%)的股东嘉善腾飞股 权投资管理有限公司(以下简称"腾飞投资"),计划在本公告披露之日起15个交 易日后的3个月内以集中竞价方式减持本公司股份不超过1,200,000股, 占本公司 总股本的0.5497%。 一、本次拟减持股东的基本情况 | 序号 | 股东名称 | 持股数量(股) | 占公司总股本比例(%) | | --- | --- | --- | --- | | 1 | 嘉善顺飞股权投资管理有限公司 | 10,526,910 | 4.8223 | | 2 | 嘉善腾飞股权投资管理有限公司 | 7,949,550 | 3.6416 | 注:截至本公告披露日,公司总股本为218,298,240股 二、本次减持计划的主要内容 1、减持原因:自身资金需求; 双飞无油轴承集团股份有限公司 关于公司股东减持股份预披露公告 公司股东嘉善顺飞股权投资管理有限公司、嘉善腾飞股权投资管理有限公司保 证向本公司提供的信息内容真实、准确、完整,没有虚假记载、误导性陈述或重大 遗漏。 本公司 ...
双飞集团: 2024年年度权益分派实施公告
Zheng Quan Zhi Xing· 2025-05-29 10:51
Group 1 - The company has approved a profit distribution plan at the annual shareholders' meeting held on May 12, 2025, which includes a cash dividend of 2.00 RMB per 10 shares, totaling 43,659,648 RMB (including tax) [1][2] - The total share capital as of December 31, 2024, is 218,298,240 shares, and the remaining undistributed profits will be carried forward to the next year [1][2] - The dividend distribution will be adjusted if there are changes in the company's share capital before the implementation period [1] Group 2 - The equity distribution plan specifies that the cash dividend will be distributed to all shareholders based on the existing total share capital, with different tax treatments for various types of shareholders [1][2] - The record date for the equity distribution is set for June 5, 2025, and the ex-dividend date is June 6, 2025 [2] - The distribution will be directly credited to the shareholders' accounts through their securities companies or other custodial institutions [2]
双飞集团(300817) - 2024年年度权益分派实施公告
2025-05-29 10:00
证券代码:300817 证券简称:双飞集团 公告编号:2025-030 双飞无油轴承集团股份有限公司 2024年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 一、股东会审议通过利润分配方案的情况 4、本次权益分派时间距离股东大会通过时间未超过两个月。 二、本次实施的权益分派方案 本公司2024年年度权益分派方案为:以公司现有总股本218,298,240股为基数,向 全体股东每10股派2.000000元人民币现金(含税;扣税后,通过深股通持有股份的香港 市场投资者、境外机构(含QFII、RQFII)以及持有首发前限售股的个人和证券投资基 金每10股派1.800000元;持有首发后限售股、股权激励限售股及无限售流通股的个人股 息红利税实行差别化税率征收,本公司暂不扣缴个人所得税,待个人转让股票时,根据 其持股期限计算应纳税额【注】;持有首发后限售股、股权激励限售股及无限售流通股 的证券投资基金所涉红利税,对香港投资者持有基金份额部分按10%征收,对内地投资 者持有基金份额部分实行差别化税率征收)。 【注:根据先进先出的原则,以投资者证券账户 ...
5月26日晚间重要公告一览
Xi Niu Cai Jing· 2025-05-26 10:11
Group 1 - Company Sun Energy plans to repurchase shares worth between 100 million to 200 million yuan for cancellation, with a maximum repurchase price of 6.69 yuan per share [1] - Company Runyang Technology intends to invest up to 300 million yuan in Shanghai Fourier Intelligent Technology Co., with a pre-investment valuation of 8 billion yuan [1] - Company Heng Rui Medicine's subsidiary has received approval for clinical trials of SHR-4712 injection for treating advanced solid tumors [2] Group 2 - Company Lianhuan Pharmaceutical plans to increase capital by 60 million yuan for its wholly-owned subsidiary [2] - Company Hongchang Electronics' subsidiary plans to increase capital by 10 million USD for its other subsidiary [2] - Company Sichuan Meifeng intends to repurchase shares worth between 50 million to 70 million yuan for cancellation, with a maximum repurchase price of 10.07 yuan per share [2] Group 3 - Company Lian Micro plans to liquidate and deregister Jiaxing Kangjing Semiconductor Industry Investment Partnership [4] - Company Jiutian Pharmaceutical has received approval for clinical trials of PDX-04 drug for treating acute gout attacks [5] - Company Pingzhi Information has signed a framework agreement with China Telecom for a GPU computing power project worth approximately 246 million yuan [7] Group 4 - Company Jiu Zhi Tang's subsidiary has initiated Phase II clinical trials for new drug YB211 aimed at treating acute bacterial skin infections [8] - Company Fosun Pharma's subsidiary has received orphan drug designation for HLX22 for gastric cancer treatment in the EU [9] - Company Jianyou Co. plans to repurchase shares worth between 20 million to 40 million yuan for employee stock ownership plans [11] Group 5 - Company Zhi Zheng Co. announced the resignation of its vice president due to personal reasons [13] - Company He Mai Co. signed a cooperation agreement for household photovoltaic systems worth 1 billion yuan [14] - Company Jinan Intelligent's subsidiary won a project bid for electric vehicle charging stations, expected to positively impact performance [16] Group 6 - Company Gaotie Electric plans to distribute a cash dividend of 0.012 yuan per share [18] - Company Guyue Longshan plans to distribute a cash dividend of 0.08 yuan per share [18] - Company Yongmaotai's shareholders plan to reduce their holdings by up to 2.66% of the company's shares [19] Group 7 - Company Tian Cheng Technology's subsidiary received a land idle fee notice for 2.1658 million yuan due to project delays [20] - Company Guangri Co. appointed a new vice president and board secretary to enhance governance [21] - Company Design General Institute won multiple major projects totaling approximately 390 million yuan [22] Group 8 - Company Fuxie Environmental signed a significant contract worth 244 million yuan for a sewage treatment project [23] - Company Lujiazui announced the resignation of its vice chairman due to job transfer [24] - Company Three Squirrels' H-share issuance application has been accepted by the CSRC [24] Group 9 - Company Kanghong Pharmaceutical's subsidiary received approval for clinical trials of KH617 for glioblastoma treatment [25] - Company Xin Zhu Co. announced a suspension of trading to plan an asset acquisition from its controlling shareholder [26] - Company Jianxin Co. announced plans for share reductions by several directors and senior management [28]